📝 Cell Point (India) Limited — results explained
Quarter ended March 2026 (Q4 FY26)
Cell Point (India) Limited reported revenue of ₹191 crore for the quarter ended March 2026 (Q4 FY26), up 11.7% from ₹171 crore in the same quarter last year.
Net profit fell 100.0% year-on-year to ₹0 crore, from ₹2 crore. Earnings per share (EPS) came in at ₹-0.07.
Operating profit stood at ₹6 crore — an operating margin (OPM) of 3.1%, compared with 1.8% in the year-ago quarter.
Full year and trailing twelve months
On a trailing-twelve-month (TTM) basis, revenue stands at ₹368 crore with a net profit of ₹0 crore.
Valuation snapshot
At the current price of ₹16.20, CELLPOINT has a market capitalisation of ₹30 crore.
Within the Speciality Retail industry, it is the 14th-largest of the 16 companies we track by market value.
Shareholding pattern
As of Mar 2026, promoters held 73.06%, foreign institutional investors (FIIs) 0.00%, public shareholders 26.94% of Cell Point (India) Limited.